Magnetoliposomes for controlled drug release in the presence of low-frequency magnetic field
about
NMR relaxation of water in nanostructures: analysis of ferromagnetic cobalt-ferrite polyelectrolyte nanocomposites.Magnetic nanosystem for cancer therapy using oncocalyxone a, an antitomour secondary metabolite isolated from a Brazilian plant.Synthesis and bio-functionalization of magnetic nanoparticles for medical diagnosis and treatment.Stabilization and functionalization of iron oxide nanoparticles for biomedical applications.Nanoparticle actuated hollow drug delivery vehicles.Structural modulation of the biological activity of gold nanoparticles functionalized with a carbonic anhydrase inhibitor.Exploring the Applicability of Nano-Poration for Remote Control in Smart Drug Delivery Systems.Extremely low frequency alternating magnetic field-triggered and MRI-traced drug delivery by optimized magnetic zeolitic imidazolate framework-90 nanoparticles.Electrochemically Stimulated Release from Liposomes Embedded in a Polyelectrolyte MultilayerMagnetic field responsive drug release from magnetoliposomes in biological fluidsMagnetic nanoparticle clusters as actuators of ssDNA releaseControlled drug release under a low frequency magnetic field: effect of the citrate coating on magnetoliposomes stabilityStructure and permeability of magnetoliposomes loaded with hydrophobic magnetic nanoparticles in the presence of a low frequency magnetic fieldSynthesis of superparamagnetic and thermoresponsive hybrid nanoparticles via surface-mediated RAFT polymerization of di(ethylene glycol) ethyl ether acrylate and (oligoethylene glycol) methyl ether acrylate
P2860
Q33841200-7B103225-8697-4616-B97F-15B07FF276F2Q37225130-334955CE-9E38-4C53-9421-D8142EC9B2F9Q37848104-87570C73-DCEB-42ED-AD7D-B8A41F237C87Q37883126-EA046555-8C32-4A21-8B75-73169D8CCE05Q37970756-3A14258C-54CB-4FA0-B682-F3B619E727A3Q45804276-9C61F63C-F7C6-462E-893B-B73B7CC3DD64Q51184948-2077A387-1980-4FC9-8A20-C6D065023654Q51546705-1D0FA876-FE4C-476D-8E65-4457424F9BDBQ57741310-011FF595-A287-411F-8DF3-BA695C807EE6Q58046734-74CBFADF-A25B-4EE3-B19D-E615A57665F7Q58046790-3C01B037-9C62-4DDD-9FAE-1493422D197BQ58046870-43BF1F38-0669-46A3-8030-B58F8A575941Q58046899-736D7E86-DACA-42DE-8CF4-2279F86D185EQ58947442-6037F1FC-B472-4141-A9D2-4AA50DCA1A64
P2860
Magnetoliposomes for controlled drug release in the presence of low-frequency magnetic field
description
im Januar 2010 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2010
@uk
name
Magnetoliposomes for controlle ...... f low-frequency magnetic field
@en
Magnetoliposomes for controlle ...... f low-frequency magnetic field
@nl
type
label
Magnetoliposomes for controlle ...... f low-frequency magnetic field
@en
Magnetoliposomes for controlle ...... f low-frequency magnetic field
@nl
prefLabel
Magnetoliposomes for controlle ...... f low-frequency magnetic field
@en
Magnetoliposomes for controlle ...... f low-frequency magnetic field
@nl
P2860
P50
P356
P1433
P1476
Magnetoliposomes for controlle ...... f low-frequency magnetic field
@en
P2093
Bengt Nordèn
P2860
P304
P356
10.1039/B915651H
P577
2010-01-01T00:00:00Z